Clinical Trial Update: Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study in kidney transplant patients evaluating the pharmacokinetics of everolimus and enteric-coated mycophenolate sodium before and aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Mycophenolate sodium (enteric-coated) (mycophenolate sodium)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED